Development and Validation of a Novel Model for Outcomes in Patients with Cirrhosis and Acute Variceal Bleeding

Background Acute variceal bleeding (AVB) in patients with cirrhosis is associated with high mortality, ranging from 12 to 20% at 6 weeks. The existing prognostic models for AVB lack precision and require further validation.